TickerFacts.

Integrated Biopharma Inc (INBP): Long-Term Debt

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-06-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Long-Term Debt is for the year ended 2023-06-30, while the company's latest annual report covers the year ended 2025-06-30. Its later filings do not report this line under the concept TickerFacts maps.

$0
As of 2023-06-30
$10.45M2012-06-30: $8.87M2013-06-30: $10.30M2014-06-30: $9.07M2015-06-30: $9.12M2016-06-30: $10.45M2017-06-30: $10.12M2018-06-30: $9.34M2019-06-30: $9.65M2020-06-30: $8.34M2021-06-30: $3.64M2022-06-30: $101.0K2023-06-30: $0$0
2012-06-30 Long-Term Debt (USD) 2023-06-30
Period endedLong-Term DebtChange YoYSource filing
2023-06-30$0-100.0%2023-09-15, Balance as of period end
2022-06-30$101.0Kn/c2023-09-15, Balance as of period end
2021-06-30$3.64M-56.4%2022-09-13, Balance as of period end
2020-06-30$8.34M-13.6%2021-09-02, Balance as of period end
2019-06-30$9.65M+3.4%2020-09-23, Balance as of period end
2018-06-30$9.34M-7.7%2019-08-29, Balance as of period end
2017-06-30$10.12M-3.2%2018-09-12, Balance as of period end
2016-06-30$10.45M+14.5%2017-09-01, Balance as of period end
2015-06-30$9.12M+0.6%2016-09-02, Balance as of period end
2014-06-30$9.07M-12.0%2015-09-04, Balance as of period end
2013-06-30$10.30M+16.1%2014-09-08, Balance as of period end
2012-06-30$8.87Mn/a2013-09-30, Balance as of period end